USH2154HExpiredUtilityPatentIndex 31
Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
Est. expiryOct 8, 2023(expired)· nominal 20-yr term from priority
C07C 303/44C07C 303/42C07B 2200/07
31
PatentIndex Score
0
Cited by
1
References
5
Claims
Abstract
A process for preparing optically pure enantiomers of R-(−)tamsulosin of formiula Ia and S-(+)tamsulosin of formula Ib by resolving racemic tamsulosin of formula I by means of (IR)-(−)-camphor-10-sulfonic acid and (1S)-(+)-camphor-10-sulfonic acid, resp., in an environment of organic solvents, water or mixtures thereof.
Claims
exact text as granted — not AI-modified1. A process for preparing optically pure enantiomers of (R)-5-(2-((2-(2-ethoxyphenoxy)-ethyl)amino)propyl)-2-methoxybenzenesulfonamide [R-(−)-tamsulosin] of formula Ia
and (S)-5-(2-((2-(2-ethoxyphenoxy)-ethyl)amino)propyl)-2-methoxybenzenesulfonamide [S-(+)-tamsulosin] of formula Ib
comprising:
(a) the resolution of racemic tamsulosin of formula I
by the treatment with (1R)-(−)-camphor-10-sulfonic acid and (1S)-(+)-camphor-10-sulfonic acid, resp., in an environment of organic solvents, water or mixtures thereof;
(b) further purification of the crystallized salt of R-(−)-tamsulosin or S-(+)-tamsulosin by crystallizing form organic solvents, water or mixtures thereof, until the desired optical purity is obtained;
(c) from the salt of R-(−)-tamsulosin or S-(+)-tamsulosin is released, by treatment with alkalis, the base of formula Ia or the base of formula Ib, resp.
2. The process of claim 1 wherein steps (a) and (b) are carried out in an environment of alcohols.
3. The process of claim 1 wherein steps (a) and (b) are carried out in an environment of water.
4. A process which comprises:
(a) preferentially precipitating one diastereomeric camphor sulfonate salt of tamsulosin from a solution containing a pair of diastereomeric camphor sulfonate salts of tamsulosin to form diastereomeric enriched precipitate and diastereomeric enriched solute.
5. The process according to claim 4 , which further comprises forming said solution by dissolving a solid mixture of a pair of diastereomeric camphor sulfonate salts of tamsulosin in a solvent.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.